StockNews.AI
VRPX
StockNews.AI
153 days

Virpax Pharmaceuticals Announces Reverse Stock Split

1. Virpax announced a 1-for-25 reverse stock split effective at 12:01 a.m. ET. 2. The company focuses on non-addictive pain management and CNS disorders.

Stock Split
-24.77%Current Return
VS
+0.66%S&P 500
$0.1303/19 08:35 AM EDTEvent Start
$0.097803/20 02:49 PM EDTLatest Updated
2m saved
Insight
Article

FAQ

Why Bearish?

Reverse stock splits often indicate company distress and can lead to negative investor sentiment. Historical examples show that such actions can result in decreased stock liquidity and market confidence.

How important is it?

The announcement of a reverse stock split could signal potential financial distress, impacting VRPX valuation. This structural change may lead to further scrutiny from investors and analysts.

Why Short Term?

The effects of a reverse split are usually immediate, affecting investor perceptions quickly. It can lead to volatility in the trading volume and price in the short term.

Related Companies

AMGNPFE
BERWYN, Pa.--(BUSINESS WIRE)--Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX) (“Virpax” or the “Company”) a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, central nervous system (CNS) disorders and anti-viral barrier indications, today announced that it will effect a 1-for-25 reverse stock split (“reverse split”) of its common stock, par value $0.0001 per share (“Common Stock”), that will become effective at 12:01 a.m. Eastern Time on.

Related News